Nutra Pharma Announces ReceptoPharm Patent for a Method of Treating Multiple Sclerosis RedNova Wed, 11 Apr 2007 9:03 AM PDT Nutra Pharma Corp. (OTCBB: NPHC), a biotechnolo

Multiple sclerosis patient not letting disease slow her down Lawrence Journal-World Tue, 10 Apr 2007 10:10 PM PDT During a recent 35-minute workout, Sue Kapfer seemed a typical healthy 55-year-old.

Modified bone marrow cells help recovery in an animal model of multiple sclerosis News-Medical-Net Tue, 10 Apr 2007 4:50 PM PDT These findings will need to be repeated in further animal models before the implications for human disease are clear; however, they open up an avenue of further research.

Curves promotes MS health The Lincoln-Way Sun Tue, 10 Apr 2007 10:15 PM PDT A new partnership exists between the Curves of Mokena and the National Multiple Sclerosis Society, Greater Illinois Chapter.

First Pharmacoeconomic Analysis With Long-Term Data Showed COPAXONE(R) Was More Cost-Effective Than Interferon Beta ... RedNova Wed, 11 Apr 2007 9:03 AM PDT A comparison of the long-term economic outcomes

Hope, risk in diabetes trial Chicago Tribune Wed, 11 Apr 2007 4:42 AM PDT A new diabetes treatment developed at Northwestern University has allowed some patients to stop taking insulin for more than two years, but it also has spurred ethical objections from researchers who say the trial put Brazilian children at unnecessary risk.

Treatment shows promise against diabetes AP via Yahoo! News Tue, 10 Apr 2007 1:00 PM PDT Thirteen young diabetics in Brazil have ditched their insulin shots and need no other medication thanks to a risky, but promising treatment with their own stem cells ? apparently the first time such a feat has been accomplished.

Stem cells shown to rein in Type 1 diabetes
Los Angeles Times Wed, 11 Apr 2007 0:15 AM PDT
Researchers say the experimental treatment left most patients 'absolutely medication-free' for months -- even years. Researchers have demonstrated for the first time that the progression of Type 1 diabetes can be halted ? and possibly reversed ? by a stem-cell transplant that preserves the body's diminishing ability to make insulin, according to a study published today.